DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Shubrook J, Colucci R, Guo A et al.
Saxagliptin: A selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus. Clin Med Insights.
Endocrinol Diabetes 2011;
4: 1-12
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.